MedTech Frameworks

A company developing a minimally invasive device typically experiences value creation in discrete scientific and regulatory steps. Investors finance the company in stages because risk declines as the device moves from concept to clinical validation. The CFO’s role is to align capital deployment with these inflection points so that the company reaches each MedTech financial milestone with sufficient resources but without carrying excess burn before value is created.